medline.ch Respirationstrakt Neoplasie

	ATF4 and SLC7A11 as biomarkers predicting progression and prognosis in lung adenocarcinoma. Front Oncol Liu Y, Guo D, Li D, Jin J. PMID: 42865719 [PubMed]
	Immune checkpoint inhibitors across neoadjuvant, perioperative, and adjuvant settings for resectable non-small-cell lung cancer: a systematic review and meta-analysis of randomized trials. Front Pharmacol Dai J, Liu M, Li H, Wang Y. PMID: 42865638 [PubMed]
	Primary pulmonary NUT carcinoma: pathological features, clinical diagnosis, treatment, and prognosis - An extended review. Oncol Rev Wu S, Zhang M, Wang H. PMID: 42865603 [PubMed]
	The real experience and coping styles of emergence delirium in patients after radical lung cancer surgery: a qualitative study. Front Psychiatry You T, Li Q, Fu Y, Wang J. PMID: 42865470 [PubMed]
	Leptomeningeal metastasis of lung adenocarcinoma presenting as cauda equina syndrome: a case report and literature review. Front Oncol Chen X, Lv H. PMID: 42865431 [PubMed]
	Clinical outcomes and prognostic factors of Ommaya reservoir-based intrathecal chemotherapy in lung cancer leptomeningeal metastasis: a retrospective cohort study. Front Oncol Yang Y, Feng M, Ong YX, Qi Z, Pokharel B, Zhang L, Wang K, Chen J, Zhou C, Chen L, Li D, Hu Z, Li L, Cao Y, Gao Y. PMID: 42865372 [PubMed]
	Evaluating immunocytochemistry performance in lung cancer cytology: An IASLC Cytology Working Group study. Cancer Cytopathol Jain D, Srebotnik-Kirbis I, Nambirajan A, Engels M, Kern I, Kim TJ, Lozano MD, Minami Y, Motoi N, Papotti M, Rekhtman N, Saqi A, Schönegg R, Wynes MW, Yatabe Y, Bubendorf L, IASLC Pathology Committee Members. PMID: 42865068 [PubMed - indexed for MEDLINE]
	Potential to improve early detection of lung cancer through expansion of focused and opportunistic screening approaches: a scoping review focusing on potential expansion of screening risk factors and adoption of artificial intelligence models. Lung Cancer Manag Mok TSK, Finley C, Köksal D, Li MSC, Shum E, Velotta JB, Yang PC. PMID: 42864862 [PubMed]
	Targeting the Tumor Microenvironment Network to Overcome Immunotherapy Resistance in Non-Small Cell Lung Cancer: Mechanisms to Clinical Translation. Cancer Med Wang Z, Luo Z, Wang L, Tang J, Zhang Z, Fan X. PMID: 42864833 [PubMed - indexed for MEDLINE]
	Who participates in LDCT screening for the early detection of lung cancer after long-term occupational exposure to asbestos dust? Results of the analysis of administrative and medical routine data from the German Social Accident Insurance. BMC Pulm Med Oubaid N, Greiner F, Keller H, Horn MA, Preisser AM, Harth V. PMID: 42864641 [PubMed - indexed for MEDLINE]
	First-line treatment outcomes in HER2-altered advanced NSCLC: a real-world multi-center study comparing trastuzumab deruxtecan with conventional therapies and analysis by HER2/EGFR co-alteration status. BMC Cancer Liu C, Li T, Qin BY, Yu L, Ji C, Liu M, Wang A, Wang YL, Liu ZF, Zhang T, Hu Y. PMID: 42864628 [PubMed - indexed for MEDLINE]
	AI-derived 3D body composition predicts prognosis of chemoimmunotherapy in small cell lung cancer: a multicenter study. J Immunother Cancer Li Y, Guo Y, Peng S, Mo P, Cheng D, Wang Y, Yang Y, Ren Y, Liang P, Liang X, Wu X, Liu C, Zhou G, Lei Z, Yang L. PMID: 42864144 [PubMed - in process]
	Identifying interoceptive awareness profiles and potential intervention targets in patients with lung cancer undergoing chemotherapy. Eur J Oncol Nurs Zhang X, Chen X, Li J, Wu X, Wang T, Teng L. PMID: 42863303 [PubMed - as supplied by publisher]
	Machine learning for differentiating primary lung cancer from pulmonary metastases and non-small cell lung cancer histological subtype classification: a systematic review. Clin Radiol Zare O, Ostovari M, Mahmoudi T. PMID: 42863195 [PubMed - as supplied by publisher]
	ReViT-RF: A hybrid ResNet-50-Vision Transformer with a Radiomic Feature Fusion framework for lung tumor classification and TNM-based stage prediction using CT images. PLoS One DA S, B RN. PMID: 42862867 [PubMed - indexed for MEDLINE]
	Primary feasibility analysis of neoadjuvant chemotherapy with bevacizumab for resectable stage II/IIIA non-squamous non-small cell lung cancer: the NAVAL phase II study. Jpn J Clin Oncol Tsubokawa N, Tsutani Y, Miyata Y, Suzuki K, Takamochi K, Tanaka F, Ito H, Yamashita Y, Oda M, Mimae T, Okada M. PMID: 42862717 [PubMed - as supplied by publisher]
	CT-guided methylene blue staining to facilitate thoracoscopic resection of intermediate-to-deep pulmonary metastases in pediatric patients. Pediatr Surg Int Obed M, Wennemann L, Linderkamp C, Pauer N, Shin HO, Vogel-Claussen J, Dingemann J, Kiblawi R. PMID: 42862376 [PubMed - indexed for MEDLINE]
	Prognostic value of diabetes-related clinical indices in patients with non-small cell lung cancer and comorbid type 2 diabetes receiving immune checkpoint inhibitor therapy. Acta Diabetol Ren Q, Zhang H, Huang D, Zhong H, Wu J, Wang Y, Zhao Y, Luo S, Li Y. PMID: 42862337 [PubMed - as supplied by publisher]
	Comparative toxicity and efficacy of consolidative thoracic radiotherapy after first-line chemoimmunotherapy in extensive-stage small-cell lung cancer: real-world retrospective cohort study. Strahlenther Onkol Bai B, Jiang Y, Meng H, Song L, Wu K, Wei J, Si N. PMID: 42862283 [PubMed - as supplied by publisher]
	Association between overall dietary antioxidant capacity and lung cancer risk: findings from two observational studies. Eur J Epidemiol Sun T, Zhang L, Luo X, Wang L, Xue Q, Song W, Li W, Tu H, Wu X. PMID: 42862260 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 163696

Seite 1 von 8185



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung